Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioExx Specialty Proteins Ltd BIXZF

"Bioexx Specialty Proteins Inc is engaged in the development and commercialization of processing technologies, for use in the extracting various active ingredients from organic and inorganic materials. The company's primary focus is on the production of proteins from canola and other oilseed feedstocks. Its products include Isolexx, a protein isolate for use in bakery products, meat products, vegetarian food products and meat analogues, and nutritional and protein bars, drinks, and supplements;


GREY:BIXZF - Post by User

Post by gadfly222on Nov 19, 2012 6:30pm
275 Views
Post# 20619678

Still alive....

Still alive....

As per Stockwatch:

 

 

Mr. Chris Schnarr reports

BIOEXX CLOSES CONVERTIBLE DEBENTURE OFFERING

BioExx Specialty Proteins Ltd. has closed its previously announced convertible debenture offering, for gross proceeds of $2,925,000.

Subscribers of the Debentures ("Debentureholders") are provided with subordinated security over the personal property of the Company and its subsidiary, BioExx Proteins of Saskatoon Inc. The Debentures bear interest at a rate of 12% per annum, and will be convertible into units (the "Units") at a conversion price of $0.10 per Unit, with each Unit being comprised of one common share in the capital of the Company (the "Common Shares") and one half of one share purchase warrant (the "Warrants"), with each whole Warrant being exercisable into one Common Share, and having a three year term and an exercise price of $0.15 per share. The Debentures mature 3 years from their date of issuance and may be repaid by the Company at any time following the first twelve months of their issuance, subject to the conversion rights of Debentureholders.

<< Previous
Bullboard Posts
Next >>